Spackman, Eldon; Rice, Stephen; Norman, Gill; Suh, … - In: PharmacoEconomics 31 (2013) 3, pp. 185-194
The National Institute for Health and Clinical Excellence (NICE) invited the manufacturer of trastuzumab, Roche Pharmaceuticals, to submit evidence for the clinical and cost effectiveness of this drug for the treatment of advanced gastric cancer (aGC), as part of the Institute’s single...